National Eye Institute Celebrating 25 Years Of Visionary Research

The National Eye Institute (NEI) celebrates its 25th anniversary this year. But, as institute director Carl Kupfer notes, while its accomplishments over the years have more than justified its formation as a separate research agency of the National Institutes of Health, it took a bit of persuasion to carry out that vision. FAR-SIGHTED FOCUS: Cal Kupfer, the institute's first director, recounts NEI's past successes and looks forward to achieving new goals in treating eye disease. "In the 1950s,

Written byNeeraja Sankaran
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The National Eye Institute (NEI) celebrates its 25th anniversary this year. But, as institute director Carl Kupfer notes, while its accomplishments over the years have more than justified its formation as a separate research agency of the National Institutes of Health, it took a bit of persuasion to carry out that vision.


FAR-SIGHTED FOCUS: Cal Kupfer, the institute's first director, recounts NEI's past successes and looks forward to achieving new goals in treating eye disease.
"In the 1950s, ophthalmic research was a small branch in the National Institute of Neurological Disease and Blindness (NINDB)," recounts Kupfer, then a professor of ophthalmology and an NINDB grantee at the University of Washington. But many ophthalmologists felt that advances in the field would be limited under a research institution whose interest encompassed the entire neurosciences. Hence, they began to lobby for the formation of an independent institute that would focus on the eye.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies